Similar articles for PMID: 19091839

Year	Number of Results
1995	1
1997	1
1999	1
2001	1
2002	1
2003	2
2004	1
2005	4
2006	4
2007	5
2008	10
2009	12
2010	16
2011	8
2012	10
2013	5
2014	2
2015	2
2016	1
2017	1
2018	1
2019	1
2024	0

1

Fatal invasive pulmonary aspergillosis associated with adalimumab therapy.

Manz M, Beglinger C, Vavricka SR. Manz M, et al. Gut. 2009 Jan;58(1):149. doi: 10.1136/gut.2008.161638. Gut. 2009. PMID: 19091839 Free article. No abstract available.

2

Systemic Mycobacterium avium complex infection during antitumor necrosis factor-α therapy in pediatric Crohn disease.

Jordan N, Waghmare A, Abi-Ghanem AS, Moon A, Salvatore CM. Jordan N, et al. J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):294-6. doi: 10.1097/MPG.0b013e31822938c3. J Pediatr Gastroenterol Nutr. 2012. PMID: 21694635 No abstract available.

3

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.

Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, Cuillerier E, Fautrel B, Michelet C, Morel J, Puéchal X, Wendling D, Lemann M, Ravaud P, Mariette X; RATIO group. Salmon-Ceron D, et al. Ann Rheum Dis. 2011 Apr;70(4):616-23. doi: 10.1136/ard.2010.137422. Epub 2010 Dec 21. Ann Rheum Dis. 2011. PMID: 21177290

4

Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.

Mañosa M, Domènech E, Marín L, Olivé A, Zabana Y, Cabré E, Gassull MA. Mañosa M, et al. Gut. 2008 Apr;57(4):559; author reply 559-60. Gut. 2008. PMID: 18334664 No abstract available.

5

First case report of adalimumab-induced psoriasis in Crohn's disease.

Harris MD, Richards R. Harris MD, et al. Am J Gastroenterol. 2009 Mar;104(3):792-3. doi: 10.1038/ajg.2008.101. Epub 2009 Feb 3. Am J Gastroenterol. 2009. PMID: 19262532 No abstract available.

6

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.

Lawrance IC, Radford-Smith GL, Bampton PA, Andrews JM, Tan PK, Croft A, Gearry RB, Florin TH. Lawrance IC, et al. J Gastroenterol Hepatol. 2010 Nov;25(11):1732-8. doi: 10.1111/j.1440-1746.2010.06407.x. J Gastroenterol Hepatol. 2010. PMID: 21039834

7

Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease.

Emmert MY, Salzberg SP, Emmert LS, Behjati S, Plass A, Felix C, Falk V, Gruenenfelder J. Emmert MY, et al. Eur J Heart Fail. 2009 Nov;11(11):1106-9. doi: 10.1093/eurjhf/hfp132. Eur J Heart Fail. 2009. PMID: 19875411 Free article.

8

Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.

Bourikas LA, Kourbeti IS, Koutsopoulos AV, Koutroubakis IE. Bourikas LA, et al. Gut. 2008 Mar;57(3):425; author reply 425-6. doi: 10.1136/gut.2007.132407. Gut. 2008. PMID: 18268059 No abstract available.

9

Invasive pulmonary aspergillosis associated with infliximab therapy.

Warris A, Bjørneklett A, Gaustad P. Warris A, et al. N Engl J Med. 2001 Apr 5;344(14):1099-100. N Engl J Med. 2001. PMID: 11291675 No abstract available.

10

Mycobacterium chelonae infection associated with adalimumab therapy.

Díaz F, Urkijo JC, Mendoza F, de la Viuda JM, Blanco M, Unzurrunzaga A, Ayarza R. Díaz F, et al. Scand J Rheumatol. 2008 Mar-Apr;37(2):159-60. doi: 10.1080/03009740701716876. Scand J Rheumatol. 2008. PMID: 18415777 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year